Who we are
Women • Health • First
Nevia Bio is a diagnostics company focused on transforming early detection, monitoring and treatment guidance for gynecological cancers. By harnessing the unique biological properties of vaginal fluid as a liquid biopsy, we aim to deliver earlier, more accurate, and more accessible diagnostic solutions—starting with ovarian cancer and expanding to the full spectrum of gynecological malignancies.
​
Using AI and multi-omics approach, we are challenging conventional assumptions in cancer care and pioneer a novel, proximity-based, non-invasive approach that gives women better outcomes, more time, and greater agency over their health.
Our
Solution
Simple vaginal swab
Biomarkers data
Ovarian cancer is also called “the silent killer". More than 310,000 cases are diagnosed every year worldwide, and 75% of patients are diagnosed at late stages, resulting in less than 30% survival rates.
Therefore, there is a growing demand for early-diagnosis solutions.
Nevia's platform will save lives of women around the world by enabling early detection.
Machine learning
Identify patients
Founders
Director & Co-founder
Inbal Zafir Lavie, PhD
Founder, CSO & Director
Shlomit Yehudai Reshef, PhD
Co-founder
Roni Michaely, PhD
Team
CEO
Scientific Project Manager and
Regulatory Affairs Specialist
Clinial Operations Manager
Dekel Gelbman, LL.B, MBA
Shiri Blumenfeld Kan, PhD, MBA
Valeria Miller, BSc, MBA
Senior Data Scientist
Senior Scientist, Life Science
Regulatory Affairs Consultant
Zohar Shnaider, BSc
Yael Teboul, MSc
Shmulik Adler
Financial Analyst
Guy Nativ
Board of Directors
Founder, CSO & Director
Chair of the board
Anula Jayasuriya
MD, PhD, MBA
Shlomit Yehudai Reshef, PhD
Director & Co-founder
Inbal Zafir Lavie, PhD
Board member
Dr. Orna Berry
Board member
Dan Shwarzman
Advisory Board
Prof. Rob Coleman
Chief Medical Officer, Vaniam Group, GOG Partners, Special Advisor to the President, GOG Foundation, Board Of Directors
Prof. Brian Slomovitz
Director, Gynicologic Oncology and CoChair, Cancer Research Committee, Mount Sinai Medical Center, Board of Directors and Uterine Cancer Lead, GOG Foundation
Prof. Eitan Friedman
Director and founder of the The Suzanne Levy-Gertner Oncogenetics Unit at the Sheba Medical Center
Prof. Ruth Perets
Medical Oncologist Rambam Division of Oncology. Head of the Women's Cancers Research Lab at Rambam Health Care Campus. Directs the Phase 1 Clinical Trials in Oncology
Dr. Orna Berry
A computer scientist, high-tech entrepreneur, and senior executive in the Israeli science and technology industries.
Serves as director of technology in the office of the CTO at Google Cloud.
Pipeline
Program
Indication
Development Stage
Biobank
Clinical
POC
FDA
Approval
Nevia-001
Nevia-002
Nevia-003
Ovarian cancer
Endometriosis
To be disclosed
Why Us
Part of Israel's Innovation Dream Team Exabition at The Peres Center For Peace & Innovation
First Place Pitch Competition
HLTH Diverse founders
Israeli femtech innovation leadership award
Top 20 most promising companies